{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:56:25Z","timestamp":1791946585144,"version":"4.3.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.vaccine.2012.01.024","type":"journal-article","created":{"date-parts":[[2012,1,15]],"date-time":"2012-01-15T04:45:55Z","timestamp":1326602755000},"page":"1951-1958","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for hemorrhagic fever with renal syndrome"],"prefix":"10.1016","volume":"30","author":[{"given":"Ellen F.","family":"Boudreau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Josleyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Ullman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lonnie","family":"Dalrymple","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Sellers-Myers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Loudon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice","family":"Rusnak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Rivard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie","family":"Schmaljohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay W.","family":"Hooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2012.01.024_bib0005","first-page":"171","article-title":"Vaccines against hantaviruses","volume":"256","author":"Hooper","year":"2001","journal-title":"Curr Top Microbiol Immunol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2012.01.024_bib0010","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1586\/14760584.8.1.67","article-title":"Recent approaches in hantavirus vaccine development","volume":"8","author":"Maes","year":"2009","journal-title":"Expert Rev Vaccines"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2012.01.024_bib0015","first-page":"675","article-title":"Epidemiology and surveillance programs on hemorrhagic fever with renal syndrome in Mainland China, 2005\u20132008","volume":"31","author":"Wang","year":"2010","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"issue":"8","key":"10.1016\/j.vaccine.2012.01.024_bib0020","doi-asserted-by":"crossref","first-page":"e789","DOI":"10.1371\/journal.pntd.0000789","article-title":"Spatiotemporal trends and climatic factors of hemorrhagic fever with renal syndrome epidemic in Shandong Province, China","volume":"4","author":"Fang","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2012.01.024_bib0025","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.3201\/eid1608.090470","article-title":"Hantavirus infections in humans and animals, China","volume":"16","author":"Zhang","year":"2010","journal-title":"Emerg Infect Dis Aug"},{"issue":"July (28)","key":"10.1016\/j.vaccine.2012.01.024_bib0030","article-title":"Situation of hantavirus infections and haemorrhagic fever with renal syndrome in European countries as of December 2006","volume":"13","author":"Heyman","year":"2008","journal-title":"Euro Surveill"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2012.01.024_bib0035","doi-asserted-by":"crossref","first-page":"6417","DOI":"10.1128\/jvi.69.10.6417-6423.1995","article-title":"A vaccinia virus-vectored Hantaan virus vaccine protects hamsters from challenge with Hantaan and Seoul viruses but not Puumala virus","volume":"69","author":"Chu","year":"1995","journal-title":"J Virol"},{"issue":"September (18)","key":"10.1016\/j.vaccine.2012.01.024_bib0040","doi-asserted-by":"crossref","first-page":"8469","DOI":"10.1128\/JVI.75.18.8469-8477.2001","article-title":"DNA vaccination with the Hantaan virus M gene protects hamsters against three of four HFRS hantaviruses and elicits a high-titer neutralizing antibody response in Rhesus monkeys","volume":"75","author":"Hooper","year":"2001","journal-title":"J Virol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2012.01.024_bib0045","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/(SICI)1096-9071(200001)60:1<77::AID-JMV13>3.0.CO;2-S","article-title":"Clinical evaluation of a vaccinia-vectored Hantaan virus vaccine","volume":"60","author":"McClain","year":"2000","journal-title":"J Med Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2012.01.024_bib0050","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0264-410X(92)90412-D","article-title":"Preparation of candidate vaccinia-vectored vaccines for haemorrhagic fever with renal syndrome","volume":"10","author":"Schmaljohn","year":"1992","journal-title":"Vaccine"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2012.01.024_bib0055","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1128\/jvi.64.7.3162-3170.1990","article-title":"Antigenic subunits of Hantaan virus expressed by baculovirus and vaccinia virus recombinants","volume":"64","author":"Schmaljohn","year":"1990","journal-title":"J Virol"},{"issue":"September (18)","key":"10.1016\/j.vaccine.2012.01.024_bib0060","doi-asserted-by":"crossref","first-page":"9894","DOI":"10.1128\/JVI.77.18.9894-9905.2003","article-title":"Active and passive vaccination against hantavirus pulmonary syndrome with Andes virus M genome segment-based DNA vaccine","volume":"77","author":"Custer","year":"2003","journal-title":"J Virol"},{"issue":"March (2)","key":"10.1016\/j.vaccine.2012.01.024_bib0065","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1006\/viro.1998.9586","article-title":"DNA vaccination with hantavirus M segment elicits neutralizing antibodies and protects against Seoul virus infection","volume":"255","author":"Hooper","year":"1999","journal-title":"Virology"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2012.01.024_bib0070","doi-asserted-by":"crossref","first-page":"9563","DOI":"10.1128\/jvi.71.12.9563-9569.1997","article-title":"Naked DNA vaccines expressing the prM and E genes of Russian spring summer encephalitis virus and Central European encephalitis virus protect mice from homologous and heterologous challenge","volume":"71","author":"Schmaljohn","year":"1997","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2012.01.024_bib0075","unstructured":"Hooper JW, inventor; United States of America, assignee. Puumala Virus Full-Length M Segment-Based DNA Vaccine. United States Patent Application US20100323024, 2010 December 23."},{"issue":"November (7\u20138)","key":"10.1016\/j.vaccine.2012.01.024_bib0080","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S0264-410X(00)00302-9","article-title":"Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine","volume":"19","author":"Roy","year":"2000","journal-title":"Vaccine"},{"issue":"September (40)","key":"10.1016\/j.vaccine.2012.01.024_bib0085","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1016\/j.vaccine.2005.05.026","article-title":"Clinical safety and efficacy of a powdered hepatitis B nucleic acid vaccine delivered to the epidermis by a commercial prototype device","volume":"23","author":"Roberts","year":"2005","journal-title":"Vaccine"},{"issue":"January","key":"10.1016\/j.vaccine.2012.01.024_bib0090","doi-asserted-by":"crossref","first-page":"6728","DOI":"10.1016\/j.vaccine.2010.12.053","article-title":"Development and application of a flow cytometric potency assay for DNA vaccines","author":"Badger","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.01.024_bib0095","series-title":"Manual of hemorrhagic fever with renalk syndrome and hantavirus pulmonary syndrome.","first-page":"87","article-title":"Enzyme-linked immunoborbent assay (ELISA)","author":"Rossi","year":"1999"},{"issue":"March (4690)","key":"10.1016\/j.vaccine.2012.01.024_bib0100","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1126\/science.2858126","article-title":"Antigenic and genetic properties of viruses linked to hemorrhagic fever with renal syndrome","volume":"227","author":"Schmaljohn","year":"1985","journal-title":"Science"},{"issue":"December (6)","key":"10.1016\/j.vaccine.2012.01.024_bib0105","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1093\/infdis\/172.6.1581","article-title":"Cross-neutralization of hantaviruses with immune sera from experimentally infected animals and from hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome patients","volume":"172","author":"Chu","year":"1995","journal-title":"J Infect Dis"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2012.01.024_bib0110","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1006\/viro.1994.1022","article-title":"Serological relationships among viruses in the Hantavirus genus, family Bunyaviridae","volume":"198","author":"Chu","year":"1994","journal-title":"Virology"},{"issue":"September (1)","key":"10.1016\/j.vaccine.2012.01.024_bib0115","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ymeth.2006.05.022","article-title":"Preclinical and clinical progress of particle-mediated DNA vaccines for infectious diseases","volume":"40","author":"Fuller","year":"2006","journal-title":"Methods"},{"issue":"March (1)","key":"10.1016\/j.vaccine.2012.01.024_bib0120","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.virol.2005.11.035","article-title":"Hantaan\/Andes virus DNA vaccine elicits a broadly cross-reactive neutralizing antibody response in nonhuman primates","volume":"347","author":"Hooper","year":"2006","journal-title":"Virology"},{"issue":"September (40)","key":"10.1016\/j.vaccine.2012.01.024_bib0125","doi-asserted-by":"crossref","first-page":"5177","DOI":"10.1016\/j.vaccine.2008.03.097","article-title":"Mixing of M segment DNA vaccines to Hantaan virus and Puumala virus reduces their immunogenicity in hamsters","volume":"26","author":"Spik","year":"2008","journal-title":"Vaccine"},{"issue":"March (Pt 10)","key":"10.1016\/j.vaccine.2012.01.024_bib0130","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1099\/0022-1317-69-10-2645","article-title":"Antigenic relationship between hantaviruses analysed by immunoprecipitation","volume":"69","author":"Sheshberadaran","year":"1988","journal-title":"J Gen Virol"},{"issue":"March (Pt 3)","key":"10.1016\/j.vaccine.2012.01.024_bib0135","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1099\/0022-1317-70-3-615","article-title":"Characterization of Hantaan virus envelope glycoprotein antigenic determinants defined by monoclonal antibodies","volume":"70","author":"Arikawa","year":"1989","journal-title":"J Gen Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12000394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12000394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:19:21Z","timestamp":1759400361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12000394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":27,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0264410X12000394"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.01.024","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for hemorrhagic fever with renal syndrome","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.01.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}